Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: Protection beyond heart rate reduction (European Heart Journal (2008) 29, (2265-2275) DOI: 10.1093/eurheartj/ehn337);Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: Protection beyond heart rate reduction

European Heart Journal

Volumn 29, Issue 18, 2008, Pages 2265-2275

  Heusch, Gerd ^a   Skyschally, Andreas ^a   Gres, Petra ^a   Van Caster, Patrick ^a   Schilawa, Dustin ^a   Schulz, Rainer ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Bradycardic agent; Heart rate; Myocardial infarction; Myocardial ischaemia; Reperfusion

Indexed keywords

IVABRADINE; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; NONHUMAN; PRIORITY JOURNAL;

EID: 52449095304     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn505     Document Type: Erratum

References (34)

1. Heusch G, Yoshimoto N. Effects of heart rate and perfusion pressure on segmental coronary resistances and collateral perfusion. Pflügers Arch 1983;397:284-289.
2. Indolfi C, Ross J Jr. The role of heart rate in myocardial ischemia and infarction: implications of myocardial perfusion-contraction matching. Prog Cardiovasc Dis 1993;36:61-74.
3. Matsuzaki M, Patritti J, Tajimi T, Miller M, Kemper WS, Ross J Jr. Effects of β-blockade on regional myocardial flow and function during exercise. Am J Physiol 1984;247:H52-H60.
4. Buck JD, Hardman HF, Warltier DC, Gross GJ. Changes in ischemic blood flow distribution and dynamic severity of a coronary stenosis induced by beta blockade in the canine heart. Circulation 1981;64:708-715.
5. Zmudka K, Dubiel J, Vanhaecke J, Flameng W, de Geest H. Effects of oral pretreatment with metoprolol on left ventricular wall motion, infarct size, hemodynamics, and regional myocardial blood flow in anesthetized dogs during thrombotic coronary artery occlusion and reperfusion. Cardiovasc Drugs Ther 1994;8:479-487.
6. Schulz R, Rose J, Skyschally A, Heusch G. Bradycardic agent UL-FS 49 attenuates ischemic regional dysfunction and reduces infarct size in swine: comparison with the β-blocker atenolol. J Cardiovasc Pharmacol 1995;25:216-228.
7. Guth BD, Heusch G, Seitelberger R, Ross J Jr. Mechanism of beneficial effect of beta-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs. Circ Res 1987;60:738-746.
8. Seitelberger R, Guth BD, Heusch G, Lee JD, Katayama K, Ross J Jr. Intracoronary alpha 2- adrenergic receptor blockade attenuates ischemia in conscious dogs during exercise. Circ Res 1988;62:436-442.
9. Simon L, Ghaleh B, Puybasset L, Giudicelli J-F, Berdeaux A. Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs. J Pharmacol Exp Ther 1995;275:659-666.
10. Heusch G, Baumgart D, Camici P, Chilian W, Gregorini L, Hess O, Indolfi C, Rimoldi O. α-Adrenergic coronary vasoconstriction and myocardial ischemia in humans. Circulation 2000;101:689-694.
11. Heusch G. Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents. Br J Pharmacol 2008;153:1589-1610.
12. Guth BD, Heusch G, Seitelberger R, Ross J Jr. Elimination of exercise-induced regional myocardial dysfunction by a bradycardic agent in dogs with chronic coronary stenosis. Circulation 1987;75:661-669.
13. Indolfi C, Guth BD, Miura T, Miyazaki S, Schulz R, Ross J Jr. Mechanisms of improved ischemic regional dysfunction by bradycardia. Studies on UL-FS 49 in swine. Circulation 1989;80:983-993.
14. Monnet X, Colin P, Ghaleh B, Hittinger L, Giudicelli J-F, Berdeaux A. Heart rate reduction during exercise-induced myocardial ischaemia and stunning. Eur Heart J 2004;25:579-586.
15. Monnet X, Ghaleh B, Colin P, Parent De Curzon O, Giudicelli J-F, Berdeaux A. Effects of heart rate reduction with ivabradine on exercise induced myocardial ischemia and stunning. J Pharmacol Exp Ther 2001;299:1133-1139.
16. Vilaine J-P, Bidouard J-P, Lesage L, Reure H, Péglion J-L. Anti-ischemic effects of ivabradine, a selective heart rate-reducing agent, in exercise-induced myocardial ischemia in pigs. J Cardiovasc Pharmacol 2003;42:688-696.
17. Gross GJ, Warltier DC, Daemmgen JW. Effects of AQ-AH 208, a new specific bradycardic agent, on myocardial ischemia-reperfusion injury in anesthetized dogs. J Cardiovasc Pharmacol 1985;7:929-936.
18. Borer JS, Fox K, Jaillon P, Lerebours G. Antianginal and antiischemic effects of ivabradine, an If inhibitor, in stable angina. Circulation 2003;107:817-823.
19. 2-receptor activation, bradykinin and prostaglandins in pigs. J Am Coll Cardiol 1998;32:1787-1796.
20. Heusch G, Rose J, Skyschally A, Post H, Schulz R. Calcium responsiveness in regional myocardial short-term hibernation and stunning in the in situ porcine heart - inotropic responses to postextrasystolic potentiation and intracoronary calcium. Circulation 1996;93:1556-1566.
21. Tanaka N, Nozawa T, Yasumura Y, Futaki S, Hiramori K, Suga H. Heart rateproportional oxygen consumption for constant cardiac work in dog heart. Jpn J Physiol 1990;40:503-521.
22. Colin P, Ghaleh B, Monnet X, Su J, Hittinger L, Giudicelli J-F, Berdeaux A. Contributions of heart rate and contractility to myocardial oxygen balance during exercise. Am J Physiol Heart Circ Physiol 2003;284:H676- H682.
23. Colin P, Ghaleh B, Monnet X, Hittinger L, Berdeaux A. Effect of graded heart rate reduction with ivabradine on myocardial oxygen consumption and diastolic time in exercising dogs. J Pharmacol Exp Ther 2004;308:236-240.
24. Gallagher KP, Matsuzaki M, Koziol JA, Kemper WS, Ross J Jr. Regional myocardial perfusion and wall thickening during ischemia in conscious dogs. Am J Physiol Heart Circ Physiol 1984;247:H727-H738.
25. Jansen J, Gres P, Umschlag C, Heinzel FR, Degenhardt H, Schlüter K-D, Heusch G, Schulz R. Parathyroid hormone-related peptide improves contractile function of stunned myocardium in rats and pigs. Am J Physiol Heart Circ Physiol 2003;284:H49-H55.
26. Ross J Jr. Myocardial perfusion-contraction matching. Circulation 1991;83:1076-1083.
27. Maroko PR, Kjekshus JK, Sobel BE,Watanabe T, Covell JW, Ross J Jr, Braunwald E. Factors influencing infarct size following experimental coronary artery occlusions. Circulation 1971;43:67-82.
28. Michels G, Brandt MC, Zagidullin N, Khan IF, Larbig R, van AS, Wippermann J, Hoppe UC. Direct evidence for calcium conductance of hyperpolarization- activated cyclic nucleotide-gated channels and human native If at physiological calcium concentrations. Cardiovasc Res 2008;78:466-475.
29. Heusch G. Postconditioning. Old wine in a new bottle? J Am Coll Cardiol 2004;44:1111-1112.
30. Skyschally A, Schulz R, Heusch G. Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning. Herz 2008;33:88-100.
31. Mulder P, Barbier S, Chagraoui A, Richard V, Henry JP, Lallemand F, Renet S, Lerebours G, Mahlberg-Gaudin F, Thuillez C. Long-term heart rate reduction induced by the selective If current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 2004;109:1674-1679.
32. Dedkov EI, Zheng W, Christensen LP, Weiss RM, Mahlberg-Gaudin F, Tomanek RJ. Preservation of coronary reserve by ivabradine-induced reduction in heart rate in infarcted rats is associated with decrease in perivascular collagen. Am J Physiol Heart Circ Physiol 2007;293:H590-H598.
33. 2+ handling in the post-infarction rat heart. Cardiovasc Res 2008;79:42-51.
34. Fox K, Ferrari R, Tendera M, Steg PG, Ford I. Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBiditymortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and leFt ventricULar dysfunction (BEAUTIFUL) study. Am Heart J 2006;152:860-866.